Dose-response Relationships Across Clinically Relevant Human Targets
Assessing Fcγ receptor (FcγR) binding is an essential part of therapeutic antibody characterization, as these interactions influence a molecule’s effector function, safety profile, and mechanism of action.
The growing global burden of neurological disorders, driven by aging populations and environmental factors, has renewed interest in this area with a focus on neuroinflammation and neurodegeneration.
Accelerate Timelines and Gather Valuable Data with a Proven and Established Portfolio of Assays and Analytical Tools
Explore Eurofins Discovery’s comprehensive CRO chemistry services, spanning Medicinal, Synthetic, Computational, and Analytical chemistry, from small-scale synthesis to full process development to enable rapid design-make-test-analyze (DMTA) cycles and accelerate your drug discovery programs.
Successful Translational Approach to Accelerate Discovery Programs
Streamline. Automate. Accelerate.
Eurofins Discovery’s SAFETYscan®47 DataViz is a complementary, customizable and interactive dashboard designed to extract, visualize, and communicate SAFETYscan47 in vitro safety pharmacology results.
Number of Active Predictions
Scalable, Affordable, Adaptable Kinase Solutions
Specialized Panel of Metabolic Receptors
De-risk your investments with our expertise.